Pendulum Therapeutics Releases In-Depth Profile of Akkermansia muciniphila, a Key Strain Forging a Path for the Future of Probiotics
SAN FRANCISCO--(BUSINESS WIRE)--Pendulum Therapeutics, the biotech company pioneering the next frontier of health through its microbiome-targeted products, today announced the release of its whitepaper, An In-Depth Profile of the Gut Commensal Akkermansia muciniphila, a proprietary bacterial strain showing promise across numerous health endpoints. Previous clinical trials evaluated this anaerobic species...
